Puneet Varma (Editor)

Vilanterol

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
CAS Number
  
503068-34-6

ECHA InfoCard
  
100.217.751

Molar mass
  
486.43 g/mol

ChemSpider ID
  
8360167

PubChem CID
  
10184665

Formula
  
C24H33Cl2NO5

ChEBI ID
  
75037

Vilanterol httpsuploadwikimediaorgwikipediacommonsthu

ATC code
  
R03AK10 (WHO) (+fluticasone) R03AL03 (WHO) (+umeclidinium)

Legal status
  
UK: POM (Prescription only) US: ℞-only In general: ℞ (Prescription only)

How to pronounce umeclidinium vilanterol anoro ellipta memorizing pharmacology video flashcard


Vilanterol (INN, USAN) is an ultra-long-acting β2 adrenoreceptor agonist (ultra-LABA), which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).

Vilanterol is available in following combinations:

  • with inhaled corticosteroid fluticasone furoate — fluticasone furoate/vilanterol (trade names Breo Ellipta (U.S.), Relvar Ellipta (EU, RU, JPN))
  • with muscarinic antagonist umeclidinium bromide — umeclidinium bromide/vilanterol (trade name Anoro Ellipta)

    • References

    Vilanterol Wikipedia
    (Text) CC BY-SA


    Similar Topics